The Drug-Induced Respiratory Disease Website
The respective role of tocolytic agents, underlying cardiac disease, fluid overload, and preeclampsia must be evaluated
Publications
[Pulmonary edema and tocolysis with beta-agonists].
Revue des maladies respiratoires 2002 Apr;19;241-4 — 2002 Apr — 241-4
The pathophysiology of pulmonary oedema with the use of beta-agonists.
BJOG : an international journal of obstetrics and gynaecology 2000 Apr;107;439-44 — 2000 Apr — 439-44
Beta adrenergic agonists and pulmonary oedema in preterm labour.
BMJ (Clinical research ed.) 1994 Jan 22;308;260-2 — 1994 Jan 22 — 260-2
Pulmonary oedema after the administration of intravenous salbutamol and ergometrine. Case report.
British journal of obstetrics and gynaecology 1980 Jun;87;539-41 — 1980 Jun — 539-41
Hemodynamic observations on pulmonary edema associated with a beta-mimetic agent. A report of two cases.
The Journal of reproductive medicine 1984 May;29;341-4 — 1984 May — 341-4
Pulmonary edema induced by betamimetic drugs.
Southern medical journal 1983 Nov;76;1354-60 — 1983 Nov — 1354-60
Pulmonary edema associated with the use of betamimetic agents in preterm labor.
American journal of hospital pharmacy 1981 Dec;38;1942-8 — 1981 Dec — 1942-8
[Fenoterol (Partusisten)-associated lung edema. A case report].
Der Anaesthesist 1986 Apr;35;258-60 — 1986 Apr — 258-60
High permeability pulmonary edema (ARDS) during tocolytic therapy--a case report.
Journal of perinatal medicine 1988;16;45-9 — 1988 — 45-9
Maternal pulmonary edema complicating beta-adrenergic therapy of preterm labor.
AJR. American journal of roentgenology 1988 Nov;151;917-8 — 1988 Nov — 917-8
Pulmonary edema associated with tocolytic therapy.
Annals of internal medicine 1989 May 01;110;714-8 — 1989 May 01 — 714-8